Imperative Care

United States · Healthtech

Develops treatments for patients suffering from thromboembolic disease

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Growth$100MAlly Bridge Group — Role not disclosedBain Capital Life Sciences — Role not disclosedBrown Advisory — Role not disclosedCatalio Capital Management — Role not disclosedElevage Medical Technologies — Role not disclosedLongaeva Partners — Role not disclosedPerceptive Advisors — Role not disclosed
Sourcesimperativecare.com ↗